Jan Hillert Selected Research

Jan Hillert Research Topics

Disease

100	Multiple Sclerosis 04/2024 - 10/2002
9	Relapsing-Remitting Multiple Sclerosis 08/2023 - 02/2003
7	Infections 04/2024 - 04/2014
6	Disease Progression 01/2023 - 02/2015
5	COVID-19 04/2024 - 12/2021
5	Obesity 11/2022 - 01/2021
5	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 06/2009
4	Genetic Predisposition to Disease (Genetic Predisposition) 04/2020 - 03/2003
3	Infectious Mononucleosis (Glandular Fever) 01/2021 - 01/2019
3	Epstein-Barr Virus Infections 01/2021 - 09/2012
3	Genetic Risk Score 04/2017 - 10/2016
3	Neuroinflammatory Diseases 04/2013 - 12/2010
2	Neoplasms (Cancer) 10/2023 - 01/2020
2	Vitamin D Deficiency 04/2020 - 12/2010
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2016 - 05/2013
2	Demyelinating Diseases (Demyelinating Disease) 11/2016 - 12/2011
2	Mental Disorders (Mental Disorder) 11/2015 - 01/2014
2	Chronic Progressive Multiple Sclerosis 02/2015 - 05/2011
2	Atrophy 09/2014 - 07/2013
2	Progressive Multifocal Leukoencephalopathy 04/2014 - 08/2011
2	Infarction (Infarctions) 09/2012 - 01/2012
2	Stroke (Strokes) 09/2012 - 01/2012
2	Inflammation (Inflammations) 12/2010 - 12/2002
2	Rheumatoid Arthritis 03/2006 - 05/2005
2	Myocardial Infarction 03/2006 - 05/2005
1	Lymphopenia (Lymphocytopenia) 10/2023
1	Herpes Zoster 10/2023
1	Pain (Aches) 08/2023
1	Fatigue 02/2023
1	Morbid Obesity 06/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Overweight 01/2021
1	Pediatric Obesity 01/2021
1	Cognitive Dysfunction 11/2019
1	Neuromyelitis Optica (Devic's Disease) 01/2018
1	Ganglion Cysts (Ganglion) 01/2017

Drug/Important Bio-Agent (IBA)

10	Oligoclonal BandsIBA 01/2021 - 09/2006
10	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021 - 07/2007
10	Interferon-betaIBA 01/2020 - 07/2007
9	Natalizumab (Tysabri)FDA Link 01/2023 - 06/2011
9	AntibodiesIBA 01/2020 - 07/2004
8	Rituximab (Mabthera)FDA Link 01/2022 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2009
5	Glatiramer Acetate (Copaxone)FDA Link 01/2023 - 07/2013
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 03/2011
5	HLA-A Antigens (HLA-A)IBA 11/2020 - 07/2007
5	Neutralizing AntibodiesIBA 01/2020 - 01/2008
5	Interleukin-7 (Interleukin 7)IBA 11/2014 - 09/2007
4	InterferonsIBA 01/2023 - 09/2010
4	EBV-encoded nuclear antigen 1IBA 10/2021 - 01/2020
4	Vitamin D FDA LinkGeneric 04/2020 - 10/2016
4	LigandsIBA 09/2014 - 10/2005
3	Fingolimod Hydrochloride (FTY720)FDA Link 10/2023 - 01/2020
3	Immunoglobulin G (IgG)IBA 03/2015 - 09/2012
3	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 04/2013 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 04/2013 - 07/2004
3	vinpocetineIBA 09/2012 - 01/2008
3	Messenger RNA (mRNA)IBA 10/2005 - 12/2003
2	teriflunomideIBA 08/2023 - 02/2022
2	Dimethyl FumarateIBA 10/2022 - 02/2022
2	AntigensIBA 01/2021 - 06/2008
2	ORALIT (ORS)IBA 01/2021 - 01/2021
2	ocrelizumabIBA 01/2020 - 01/2018
2	Retinaldehyde (Retinal)IBA 11/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 10/2003
2	B-Cell Activating FactorIBA 01/2017 - 07/2004
2	Integrin alpha4beta1 (VLA-4)IBA 04/2014 - 09/2007
2	Interferon-gamma (Interferon, gamma)IBA 12/2009 - 05/2005
2	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 09/2007 - 03/2006
2	MHC class II transactivator proteinIBA 03/2006 - 05/2005
1	Cladribine FDA LinkGeneric 10/2023
1	TabletsIBA 10/2023
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2023
1	3-((4-azidophenyl)dithio)propionic N-hydroxysuccinimide (SADP)IBA 01/2023
1	AutoantigensIBA 04/2022
1	SmokeIBA 01/2022
1	FurinIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Alemtuzumab (Campath)FDA Link 01/2020
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2020
1	AnoctaminsIBA 01/2019
1	Epstein-Barr Virus Nuclear AntigensIBA 01/2019
1	Blood Proteins (Serum Proteins)IBA 01/2019
1	Prescription DrugsIBA 07/2018
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2018
1	CytokinesIBA 01/2017
1	Methionine (L-Methionine)FDA Link 01/2017
1	EnzymesIBA 01/2017
1	AutoantibodiesIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2016

Therapy/Procedure

24	Therapeutics 04/2024 - 07/2007
2	Bariatric Surgery 11/2022 - 06/2021
1	Contraception (Birth Control) 03/2024
1	Immunotherapy 08/2023
1	Nicotine Replacement Therapy 01/2023
1	Critical Care (Surgical Intensive Care) 01/2022
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 06/2021
1	Gastrectomy 06/2021
1	Off-Label Use 01/2020
1	Injections 01/2020